1. Home
  2. NVCR vs CEPU Comparison

NVCR vs CEPU Comparison

Compare NVCR & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CEPU
  • Stock Information
  • Founded
  • NVCR 2000
  • CEPU 1989
  • Country
  • NVCR Switzerland
  • CEPU Argentina
  • Employees
  • NVCR N/A
  • CEPU N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CEPU Electric Utilities: Central
  • Sector
  • NVCR Health Care
  • CEPU Utilities
  • Exchange
  • NVCR Nasdaq
  • CEPU Nasdaq
  • Market Cap
  • NVCR 1.9B
  • CEPU 1.6B
  • IPO Year
  • NVCR 2015
  • CEPU 2018
  • Fundamental
  • Price
  • NVCR $19.11
  • CEPU $13.03
  • Analyst Decision
  • NVCR Buy
  • CEPU Hold
  • Analyst Count
  • NVCR 6
  • CEPU 1
  • Target Price
  • NVCR $32.83
  • CEPU $12.00
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • CEPU 366.8K
  • Earning Date
  • NVCR 07-24-2025
  • CEPU 05-12-2025
  • Dividend Yield
  • NVCR N/A
  • CEPU 2.38%
  • EPS Growth
  • NVCR N/A
  • CEPU N/A
  • EPS
  • NVCR N/A
  • CEPU 0.06
  • Revenue
  • NVCR $621,711,000.00
  • CEPU $697,204,690.00
  • Revenue This Year
  • NVCR $5.56
  • CEPU $26.57
  • Revenue Next Year
  • NVCR $9.15
  • CEPU N/A
  • P/E Ratio
  • NVCR N/A
  • CEPU $22.04
  • Revenue Growth
  • NVCR 18.27
  • CEPU N/A
  • 52 Week Low
  • NVCR $14.17
  • CEPU $7.07
  • 52 Week High
  • NVCR $34.13
  • CEPU $16.60
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • CEPU 56.54
  • Support Level
  • NVCR $18.66
  • CEPU $13.07
  • Resistance Level
  • NVCR $20.06
  • CEPU $13.65
  • Average True Range (ATR)
  • NVCR 0.86
  • CEPU 0.69
  • MACD
  • NVCR 0.19
  • CEPU 0.02
  • Stochastic Oscillator
  • NVCR 71.98
  • CEPU 52.99

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CEPU Central Puerto S.A. (each represents ten)

Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.

Share on Social Networks: